Glycosaminoglycan Recognition by YKL-40: Potential Regulation in Disease
- 1Genis, 580 Siglufjordur, Iceland
- 2School of Health, Business, and Natural Sciences, University of Akureyri, 600 Akureyri, Iceland
- 3School of Engineering and Natural Sciences, Science Institute, Department of Biochemistry, University of Iceland, 102 Reykjavik, Iceland
Abstract
YKL-40 (CHI3L1) is a secreted chitinase-like protein involved in inflammation, tissue remodeling, angiogenesis, and cancer. Although its biological activities have been extensively investigated, the molecular mechanisms regulating its extracellular interactions remain incompletely understood. YKL-40 binds several glycosaminoglycans (GAGs), including heparin (hep), heparan sulfate (HS), dermatan sulfate (DS), and hyaluronan (HA). YKL-40-GAG interactions are influenced by the GAG chain length, sulfation, and uronic acid composition, suggesting that YKL-40 selectively recognizes specific structural features of GAG chains rather than electrostatic interactions alone. YKL-40 is known to interact with the HS-containing cell-surface receptors CD44v3, syndecan-1, and syndecan-4, which have been implicated in YKL-40-mediated signaling associated with tumor progression and angiogenesis. Because HS structures are dynamically regulated through sulfation and the C5-epimerization of D-glucuronic acid (GlcA) to L-iduronic acid (IdoA), pathological remodeling may alter the binding properties of HS chains of these receptors. This hypothesis-driven review examines the structural determinants of YKL-40-GAG recognition and proposes a mechanism by which disease-associated changes in HS sulfation, the uronic acid composition, and motif organization could alter YKL-40 binding affinity for HS-containing receptors, potentially influencing their downstream signaling. However, whether such remodeling directly alters YKL-40 binding or signaling remains to be experimentally established. Understanding how receptor-associated HS structures influence YKL-40 recognition may provide new insights into its context-dependent biological activity and potential therapeutic targeting.
Related
- Dual Carbohydrate Recognition by the Chitinase-like Protein CHI3L1 Through Distinct Glycosaminoglycan and Chitin-Binding Interfaces
- dsRNA: mechanisms of gene expression regulation, disease pathogenesis, and therapeutic potential
- Epigenetic Regulation of Pyroptosis in Kidney Disease: From Molecular Mechanisms to Therapeutic Potential
- Bone-Directed Drug Delivery: From Mineral and Matrix Recognition to Cellular Regulation
- Sialic Acids: From Biosynthesis and Molecular Recognition to Disease and Therapy
BibTeX
@article{magnusdottir2026glycosaminoglycan,
title = {{Glycosaminoglycan Recognition by YKL-40: Potential Regulation in Disease}},
author = {Unnur Magnusdottir and Kristinn R. Oskarsson and Jens G. Hjorleifsson and Jon M. Einarsson and Finnbogi R. Thormodsson},
journal = {Biomolecules},
year = {2026},
month = nov,
doi = {10.3390/biom16111659},
url = {https://www.mdpi.com/2218-273X/16/11/1659},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Glycosaminoglycan Recognition by YKL-40: Potential Regulation in Disease
AU - Unnur Magnusdottir
AU - Kristinn R. Oskarsson
AU - Jens G. Hjorleifsson
AU - Jon M. Einarsson
AU - Finnbogi R. Thormodsson
PY - 2026
DA - 2026/11/13
JO - Biomolecules
DO - 10.3390/biom16111659
UR - https://www.mdpi.com/2218-273X/16/11/1659
AB - YKL-40 (CHI3L1) is a secreted chitinase-like protein involved in inflammation, tissue remodeling, angiogenesis, and cancer. Although its biological activities have been extensively investigated, the molecular mechanisms regulating its extracellular interactions remain incompletely understood. YKL-40 binds several glycosaminoglycans (GAGs), including heparin (hep), heparan sulfate (HS), dermatan sulfate (DS), and hyaluronan (HA). YKL-40-GAG interactions are influenced by the GAG chain length, sulfation, and uronic acid composition, suggesting that YKL-40 selectively recognizes specific structural features of GAG chains rather than electrostatic interactions alone. YKL-40 is known to interact with the HS-containing cell-surface receptors CD44v3, syndecan-1, and syndecan-4, which have been implicated in YKL-40-mediated signaling associated with tumor progression and angiogenesis. Because HS structures are dynamically regulated through sulfation and the C5-epimerization of D-glucuronic acid (GlcA) to L-iduronic acid (IdoA), pathological remodeling may alter the binding properties of HS chains of these receptors. This hypothesis-driven review examines the structural determinants of YKL-40-GAG recognition and proposes a mechanism by which disease-associated changes in HS sulfation, the uronic acid composition, and motif organization could alter YKL-40 binding affinity for HS-containing receptors, potentially influencing their downstream signaling. However, whether such remodeling directly alters YKL-40 binding or signaling remains to be experimentally established. Understanding how receptor-associated HS structures influence YKL-40 recognition may provide new insights into its context-dependent biological activity and potential therapeutic targeting.
SN - 2218-273X
ER -